Outer membrane vesicle: A macromolecule with multifunctional activity

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 7, 2012, Pages 953-955

  Moshiri, Arfa ^a   Dashtbani Roozbehani, Abolfazl ^b   Peerayeh, Shahin Najar ^c   Siadat, Seyed Davar ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Adjuvant; Neisseria meningitidis; Outer membrane vesicle; Vaccine development

Indexed keywords

BACTERIAL VACCINE; BRUCELLA VACCINE; HEPATITIS B SURFACE ANTIGEN; MENINGOCOCCUS VACCINE;

ANTIBODY PRODUCTION; BRUCELLOSIS; CELL ACTIVITY; CONFORMATIONAL TRANSITION; DRUG BINDING; DRUG DESIGN; DRUG EFFECT; DRUG SAFETY; DRUG USE; HUMAN; MACROMOLECULE; MEMBRANE VESICLE; NEISSERIA MENINGITIDIS; NONHUMAN; NOTE; UNSPECIFIED SIDE EFFECT; VACCINE PRODUCTION;

EID: 84864114471     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20166     Document Type: Note

References (14)

1. Salmani AS, Siadat SD, Norouzian D, Izadi Mobarakeh J, Kheirandish M, Zangeneh M, et al. Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as an Adjuvant to Induce Specific Antibody Response against the Lipopolysaccharide of Brucella abortus S99. Ann Microbiol 2009; 59:145-9; http://dx.doi.org/10.1007/BF03175612.
2. Stephens DS. Outer-membrane-vesicle vaccines: old but not forgotten. Lancet Infect Dis 2011; 11:421-2; PMID:21489883; http://dx.doi.org/10.1016/ S1473-3099(11)70096-2.
3. Siadat SD, Norouzian D. Meningococcal vaccines: past, present and future perspectives. J Infect Dev Ctries 2007; 1:122-39.
4. Siadat SD, Naddaf SR, Zangeneh M, Moshiri A, Sadat SM, Shafiee Ardestani M, et al. Outer membrane vesicle of Neisseria meningitidis serogroup B as an adjuvant in immunization of rabbit against Neisseria meningitidis serogroup A. African J Microb Res 2011; 5:3090-5.
5. Oliver KJ, Reddin KM, Bracegirdle P, Hudson MJ, Borrow R, Feavers IM, et al. Neisseria lactamica protects against experimental meningococcal infection. Infect Immun 2002; 70:3621-6; PMID:12065503; http://dx.doi.org/10.1128/IAI.70.7. 3621-3626.2002.
6. Sánchez S, Troncoso G, Criado MT, Ferreirós C. In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica. Vaccine 2002; 20:2957-63; PMID:12126908; http://dx.doi.org/10.1016/S0264-410X(02)00224-4.
7. Sardiñas G, Reddin K, Pajon R, Gorringe A. Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant. Vaccine 2006; 24:206-14; PMID:16115701; http://dx.doi.org/10.1016/j.vaccine.2005.07.064.
8. Bhattacharjee AK, Izadjoo MJ, Zollinger WD, Nikolich MP, Hoover DL. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect Immun 2006; 74:5820-5; PMID:16988260; http://dx.doi.org/10.1128/IAI.00331-06.
9. Siadat SD, Shirdast H, Aghasadeghi MR, Norouzian D, Atyabi SM, Sadat SM, et al. Determination of cytokine profile following the immunization with Brucella abortus S99 lipopolysaccharide-Neisseria meningitidis serogroup B outer membrane vesicle complex in animal model. Research Scientific Journal. Ardabil University of Medical Sciences 2010; 10:223-32.
10. Siadat SD, Behzadiannejad Q, Tabaraie B, Ahmadi H, Norouzian D, Najar Peerayeh S. Evaluation of serum bactericidal activity specific for Neisseria meningitidis serogroup A and B: Effect of immunization with Neisseria meningitidis serogroup A polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent Meningococcus vaccine candidate. Res J Microbiol 2007; 2:436-44; http://dx.doi.org/10.3923/jm.2007.436.444.
11. Siadat SD, Norouzian D, Tabaraie B, Ahmadi H, Behzadiyannejad Q, Najar Pirayeeh S. Comparative studies of conjugated capsular polysaccharide of Neisseria meningitidis serogroup A with outer membrane vesicle of Neisseria meningitidis serogroup B. Res J Microbiol 2007; 2:337-45; http://dx.doi.org/10. 3923/jm.2007.337.345.
12. Kheirandish M, Siadat SD, Norouzian D, Razavi MR, Aghasadeghi MR, Rezaei N. Measurement of opsonophagocytic activity of antibodies specific to Neisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate in animal model. Ann Microbiol 2009; 59:801-6; http://dx.doi.org/10.1007/BF03179226.
13. Pinto VB, Moran EE, Cruz F, Wang XM, Fridman A, Zollinger WD, et al. An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups. Vaccine 2011; 29:7752-8; PMID:21827811; http://dx.doi.org/10.1016/j.vaccine. 2011.07.124.
14. Aghasadeghi MR, Salmani AS, Sadat SM, Javadi F, Memarnejadian A, Vahabpour R, et al. Application of Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1. Curr HIV Res 2011; 9:630-5; PMID:22211657; http://dx.doi.org/10.2174/157016211798998772.